4 April 2019

In agreement with the existing policy the research board and Radboudumc Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications.

The internal review of KWF project proposals is meant to improve the quality of the proposals and thereby raising the chance of awarding. The internal review procedure is in place for all types of projects granted by KWF. Please be aware the pre-application deadline in case of Infrastructure initiatives.

Please find here the schedule for the internal KWF review procedure. We kindly ask you to adhere to it.  
 
Important internal deadlines are:  
  • 4 February 2019: Opens pre-submission Infrastucture initatives 
  • 6 March  2019: KWF deadline pre-submission  Infrastucture initatives 
  • 10 April 2019: Registration of new application    
  • 24 April 2019: Internal submission of full application 
  • 5 June 2019 (12:00): KWF deadline 
Also, please anticipate the possibility that you will be asked to review a draft application of one of your colleagues in the upcoming round between 24 April – 15 May 2019.  

Information on the KWF Program Research & Implementation can be found on the KWF website. 

Related news items


Social media posts on medication use during pregnancy often incorrect

23 August 2019

Dutch social media regularly post about the safety of medicines for pregnant women. Many pregnant women use these posts as a source of information. A new analysis shows, however, that information found on social media about the risk of medication use often does not correspond with guidelines.

read more

Hans van Bokhoven newly elected in Academia Europaea

22 August 2019

The Academia Europaea is a functioning European Academy of Humanities, Letters and Sciences, composed of individual members.

read more

Drug-induced interstitial lung disease in advanced breast cancer patients receiving everolimus

22 August 2019

In Targeted Oncology, Annelieke Willemsen, Carla van Herpen and colleagues, showed that pulmonary function test with diffusion capacity of the lungs for carbon monoxide and serum biomarkers can be of aid to differentiate everolimus-related interstitial lung disease from other respiratory problems.

read more

Publication in PNAS on dissecting EEC syndrome using single-cell RNA-seq

22 August 2019

PhD candidates Eduardo Soares and Quan Xu in Jo Huiqing Zhou’s group in Molecular Developmental Biology, theme Reconstruction and regenerative medicine, have published a paper in PNAS on the disease mechanism of EEC syndrome using single-cell RNA-seq technology and patient-derived iPSCs.

read more

Patient trust and participation in cell biological research

21 August 2019

Alessandra Cambi and Gert Olthuis, discuss key ethical issues inherent in the development and the value of building trust and trustworthiness.

read more

NWO grant for a tissue-generating patch to close diaphragmatic defects

21 August 2019

Willeke Daamen and Toin van Kuppevelt, theme Reconstructive and regenerative medicine, were recently awarded a 690 k€ grant by NWO, domain Applied & Engineering Sciences, for the development of advanced patches for closure of diaphragmatic defects in children with congenital diaphragmatic hernia.

read more